全球疼痛管理药及设备市场 是由出版商BCC Research在2009年08月所出版的。
这份英文市场调查报告书包含195 pages 价格从美金4850起跳。
全球疼痛管理药及疼痛管理设备市场在2008年达到191亿美元的规模，预计在2013年之前将达到328亿美元的规模。未来5年的成长率预计为CAGR11.5%。
本报告书内容包括：疼痛管理领域的药品及设备市场分析、产业动向、疼痛治疗药、市场规模、市场中主要企业介绍等。内容纲要摘记如下：
第1章 介绍
第2章 摘要
第3章 产业概要
- 疼痛管理及疼痛治疗的发展历史
- 疼痛诊断方法
- 疼痛治疗方法
- 美国高龄化
第4章 产业动向
- 非麻醉性药品
- 未治疗问题
- 疼痛治疗及专家面临的课题
- 经管理护理的疼痛管理问题
- 癌症疼痛的新开发
- 利用鸦片类药品减少便秘及并发症
- 非专利药品的进入
- 未来的疼痛研究
第5章 疼痛治疗
- 利用药品的疼痛管理
- OTC药
- 疼痛管理设备
- 疼痛管理处置
- 疼痛管理的替代方法
- 疼痛管理服务
第6章 处方疼痛管理市场规模及分析
- 市场整体介绍
- 产品别市场
- 进入市场企业
- 未来市场分析
第7章 疼痛管理设备市场规模及分析
- 市场整体介绍
- 产品别市场
- 进入市场企业
- 未来市场分析
第8章 市场总结
第9章 企业介绍
- 疼痛管理药制造商
- ABBOTT LABORATORIES
- ASTRAZENECA
- BARR LABORATORIES, INC
- BAXTER INTERNATIONAL
- BRISTOL-MYERS SQUIBB CO
- ELI LILLY & CO
- GLAXOSMITHKLINE
- MEDTRONIC, INC
- MERCK & CO. INC
- ORTHO-MCNEIL PHARMACEUTICALS
- PFIZER
- WYETH
附录
Abstract
REPORT HIGHLIGHTS
- The global market for pain management pharmaceuticals and devices amounted
to $19.1 billion in 2008 and is expected to increase to $32.8 billion in 2013.
The compound annual growth rate (CAGR) for the 5-year period is projected at
11.5%.
- The pharmaceuticals segment dominated the market at $17.6 billion in 2008.
That figure is expected to increase to $30.2 billion in 2013, for a CAGR of
11.5%.
- The devices segment of the market generated $1.48 billion in sales in 2008
and is projected to increase to $2.5 billion in 2013, for a CAGR of 11.4%.
Table of Contents
Chapter- 1: INTRODUCTION -- Complimentary 3
- STUDY GOALS AND OBJECTIVES 1
- REASONS FOR DOING THE STUDY 1
- SCOPE OF REPORT 1
- METHODOLOGY 2
- ANALYST CREDENTIALS 2
- RELATED BCC STUDIES 2
- BCC RESEARCH ONLINE SERVICES 3
- DISCLAIMER 3
Chapter-2: SUMMARY 2
- HISTORY OF PAIN AND PAIN TREATMENT 6
- THE PERCEPTION OF PAIN 7
- Types of Pain 8
- Acute Pain 8
- Chronic Pain 8
- ASSESSMENT OF PAIN 9
- Subjective 9
- Objective 9
- TABLE 1 OBJECTIVE SIGNS OF PAIN 10
- HOW PAIN IS DIAGNOSED 10
- THERMOGRAPHY 11
- HOW PAIN IS TREATED 11
- FIGURE 1 PAIN-MANAGEMENT TECHNIQUES 11
- HOW PAIN IS TREATED (CONTINUED) 12
- HOW PAIN IS TREATED (CONTINUED) 13
- HOW PAIN IS TREATED (CONTINUED) 14
- HOW PAIN IS TREATED (CONTINUED) 15
- HOW PAIN IS TREATED (CONTINUED) 16
- HOW PAIN IS TREATED (CONTINUED) 17
- THE AGING U.S. POPULATION 18
- TABLE 2 U.S. POPULATION ESTIMATES BY AGE GROUP AND GENDER, 1950 AND 2000
(MILLIONS) 18
- FIGURE 2 U.S. POPULATION ESTIMATES, BY AGE GROUP, 1950 AND 2000 (MILLIONS)
19
- FIGURE 3 U.S. POPULATION ESTIMATES BY GENDER, 1950 AND 2000 (MILLIONS) 19
- TABLE 3 U.S. POPULATION PROJECTIONS BY AGE GROUP AND GENDER FOR SPECIFIC
YEARS, 2010-2050 (MILLIONS) 20
- FIGURE 4 U.S. POPULATION PROJECTIONS, BY SELECTED AGE GROUP FOR SPECIFIC
YEARS, 2010-2050 (MILLIONS) 20
- FIGURE 5 U.S. POPULATION PROJECTIONS, BY GENDER FOR SPECIFIC YEARS,
2010-2050 (MILLIONS) 21
- WORLD DEMOGRAPHICS 21
- TABLE 4 WORLD POPULATION GROWTH BY GEOGRAPHICAL REGION, 2008 AND 2013
(MILLIONS) 21
- TABLE 4 (CONTINUED) 22
- FIGURE 6 WORLD POPULATION BY GEOGRAPHICAL REGION, 2008 AND 2013 (MILLIONS)
22
- TABLE 5 ESTIMATED AND PROJECTED WORLD POPULATION BY AGE AND GENDER, 2008
AND 2013 23
- FIGURE 7 ESTIMATED AND PROJECTED WORLD POPULATION BY AGE AND GENDER, 2008
AND 2013 (MILLIONS) 23
- LIFE EXPECTANCY FOR MEN AND WOMEN 23
- TABLE 6 CURRENT AND PROJECTED U.S. LIFE EXPECTANCY AT BIRTH BY GENDER AND
YEAR, 2000-2020 (YEARS) 24
- FIGURE 8 CURRENT AND PROJECTED U.S. LIFE EXPECTANCY AT BIRTH BY GENDER AND
YEAR, 2000-2020 (YEARS) 24
- INCIDENCE OF PAIN 25
- PREVALENCE OF PAIN 25
- Severe Headache or Migraine, Low Back, and Neck Pain 25
- TABLE 7 SEVERE HEADACHE OR MIGRAINE, LOW BACK PAIN, AND NECK PAIN AMONG
ADULTS, 18 YEARS OF AGE AND OVER*, 1997-2009 (%) 26
- FIGURE 9 SEVERE HEADACHE OR MIGRAINE, LOW BACK PAIN, AND NECK PAIN AMONG
ADULTS, 18 YEARS OF AGE AND OVER*, 1997-2009 (%) 26
- Joint Pain 27
- TABLE 8 JOINT PAIN AMONG ADULTS 18 YEARS OF AGE AND OVER*, 2002-2009 (%) 27
- FIGURE 10 JOINT PAIN AMONG ADULTS 18 YEARS OF AGE AND OVER*, 2002-2009 (%)
28
- Cancer Pain 28
- Cancer Pain (Continued) 29
- FIGURE 11 CAUSES OF CANCER PAIN 30
- Pain Management in Cancer 30
- TABLE 9 CANCER PAIN MEDICATION 31
- Description of Some of Key Medications for Cancer Pain Control 31
- Morphine 31
- Fentanyl 32
- Hydromorphone 32
- Methadone 32
- Buprenorphine 33
- Oxycodone 33
- Diamorphine 33
- HIV/AIDS Related Pain 33
- TABLE 10 ESTIMATED HIV REPORTED CASES BY SELECTED CHARACTERISTICS, 2007 34
- FIGURE 12 ESTIMATED HIV REPORTED CASES BY AGE GROUP, 2007 34
- FIGURE 13 ESTIMATED HIV REPORTED CASES BY GENDER, 2007 35
- FIGURE 14 ESTIMATED HIV REPORTED CASES BY RACE, 2007 35
- Burn Pain 35
- Burn Classifications 36
- TABLE 11 BURN CLASSIFICATIONS 36
- Stages of Burn Healing 37
- Stages of ... (Continued) 38
- Challenges Associated with Burn Pain 39
- Burn Pain Management 39
- FIGURE 15 BURN PAIN MANAGEMENT APPROACH 40
- Dental Pain 40
- Treatment for Dental Pain 41
- GENDER AND PAIN 41
- TABLE 12 PAIN BY SELECTED CATEGORY AND GENDER IN THE 18+ U.S. POPULATION*,
1997-2006 (%) 42
- FIGURE 16 PAIN BY SELECTED CATEGORY AND GENDER IN THE 18+ U.S.
POPULATION*, 1997-2006 (%) 43
- OTHER INFLUENCES DETERMINING HOW PAIN IS FELT AMONG INDIVIDUALS 43
- Objective Pain Measurement 44
- OBSTETRICS PAIN 44
- ORTHOPEDIC PAIN 44
- PEDIATRIC PAIN 44
- Pediatric Pain (Continued) 45
- SURGICAL PAIN 46
- GLOBAL PAIN MANAGEMENT 47
Chapter-3: INDUSTRY OVERVIEW 42
Chapter-4: INDUSTRY TRENDS 35
- PHARMACEUTICAL PAIN MANAGEMENT 83
- PRESCRIPTION PAIN MANAGEMENT PRODUCTS 83
- Analgesic Drugs 83
- Non-Narcotic 84
- Narcotic 84
- Narcotic (Continued) 85
- Narcotic (Continued) 86
- Full and Partial Agonists 87
- Agonist-Antagonists 88
- Nonsteroid Anti-inflammatory Drugs 89
- Anti-migraine Drugs 90
- Anti-migraine Drugs (Continued) 91
- TABLE 23 RECENT APPLICATIONS/APPROVALS, THROUGH 3/2009 92
- Antidepressant, Anticonvulsants, and Other Pain Relieving Drugs 92
- ANESTHETICS 93
- General 93
- TABLE 24 MOST COMMONLY USED GENERAL ANESTHETIC AGENTS 94
- Local/Regional 94
- Topical 95
- OVER-THE-COUNTER PAIN MANAGEMENT PRODUCTS 95
- ANALGESIC DRUGS 95
- TABLE 25 ACETAMINOPHEN AND ACETAMINOPHEN COMBINATION PRODUCTS 96
- NONSTEROID ANTI-INFLAMMATORY DRUGS 97
- Aspirin Products and Aspirin Combination Products 97
- TABLE 26 ASPIRIN AND ASPIRIN COMBINATION PRODUCTS 98
- Ibuprofen and Ibuprofen Combination Products 98
- TABLE 27 IBUPROFEN AND IBUPROFEN COMBINATION PRODUCTS 98
- Ketoprofen Products 99
- TABLE 28 KETOPROFEN PRODUCTS 99
- Naproxen Compounds 99
- TABLE 29 OTC NONSTEROID ANTI-INFLAMMATORIES 99
- ANTI-MIGRAINE DRUGS 100
- TABLE 30 ANTI-MIGRAINE PRODUCTS 100
- TOPICAL ANESTHETIC DRUGS 100
- TABLE 31 TOPICAL ANESTHETIC PRODUCTS 101
- PAIN MANAGEMENT DEVICES 101
- TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS 102
- PAIN TEM 103
- SPINAL CORD STIMULATORS 104
- NEUROMUSCULAR STIMULATORS 105
- Neuromuscular Stimulators (Continued) 106
- Neuromuscular Stimulators (Continued) 107
- OTHER PAIN MANAGEMENT DEVICES 108
- PAIN MANAGEMENT PROCEDURES 109
- ALTERNATIVE METHODS OF PAIN MANAGEMENT 109
- ALTERNATIVE METHODS OF PAIN ... (CONTINUED) 110
- Psychological Therapies 111
- Biofeedback 112
- Hypnosis 113
- Behavior Modification/Operant Conditioning 113
- Relaxation and Stress Management Training 113
- Imagery 114
- Autogenic Training 114
- Psychosocial Interventions 115
- Distraction and Reframing 115
- Ice 116
- Warm Bath 116
- Massage 116
- Joint Mobilization 117
- Manipulation 117
- Traction 117
- Acupuncture/Acupressure 117
- Acupuncture/Acupressure (Continued) 118
- Laser Therapy 119
- Surgery 119
- Radiation Therapy 120
- Radio Frequency Neuroablation, Epiduroscopy 120
- PAIN MANAGEMENT SERVICES 121
- HOME CARE 121
- HOSPICE 122
- NATIONAL HOSPICE ORGANIZATION 123
- TABLE 32 NHO COMMITTEES 124
- HOSPITALS 124
- PAIN CLINICS 125
- SKILLED NURSING FACILITIES 126
Chapter-5: TREATING PAIN 44
Chapter-6: PRESCRIPTION PAIN MANAGEMENT MARKET SIZE AND ANALYSIS 6
- TOTAL MARKET 127
- PRESCRIPTION PAIN MARKETS BY PRODUCT TYPE 127
- TABLE 33 WORLDWIDE PRESCRIPTION PAIN MANAGEMENT PHARMACEUTICALS MARKET,
THROUGH 2013 ($ MILLIONS) 128
- FIGURE 20 WORLDWIDE PRESCRIPTION PAIN MANAGEMENT PHARMACEUTICALS MARKET,
2006-2013 ($ MILLIONS) 128
- MARKET PARTICIPANTS 129
- TABLE 34 GLOBAL PRESCRIPTION NARCOTIC AND NSAIDS MANUFACTURER MARKET SHARE
BY MANUFACTURER, 2008 ($ MILLIONS) 129
- FIGURE 21 GLOBAL PRESCRIPTION NARCOTIC AND NSAIDS MANUFACTURER MARKET
SHARE BY MANUFACTURER, 2008 ($ MILLIONS) 130
- TABLE 35 GLOBAL PRESCRIPTION ANTI-MIGRAINE DRUG MANUFACTURER MARKET SHARE
BY MANUFACTURER, 2008 ($ MILLIONS) 130
- FIGURE 22 GLOBAL PRESCRIPTION ANTI-MIGRAINE DRUG MANUFACTURER MARKET SHARE
BY REVENUE, 2008 (%) 131
- TABLE 36 GLOBAL PRESCRIPTION ANESTHESIA MANUFACTURER MARKET SHARE BY
MANUFACTURER, 2008 ($ MILLIONS) 131
- FIGURE 23 GLOBAL PRESCRIPTION ANESTHESIA MANUFACTURER MARKET SHARE BY
MANUFACTURER, 2008 (%) 132
- FUTURE MARKET ANALYSIS 132
Chapter-7: PAIN MANAGEMENT DEVICE MARKET SIZE AND ANALYSIS 5
- TOTAL PAIN MANAGEMENT DEVICE MARKET 133
- PAIN MARKETS BY PRODUCT TYPE 133
- TABLE 37 GLOBAL PAIN MANAGEMENT DEVICES MARKET AT MANUFACTURERS' SALES
LEVELS BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS) 134
- FIGURE 24 GLOBAL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT TYPE, THROUGH
2013 ($ MILLIONS) 135
- MARKET PARTICIPANTS 135
- TABLE 38 GLOBAL NEUROMUSCULAR STIMULATOR/TENS MANUFACTURER MARKET SHARE BY
MANUFACTURER, 2008 ($ MILLIONS) 136
- FIGURE 25 GLOBAL NEUROMUSCULAR STIMULATOR/TENS UNIT MANUFACTURER MARKET
SHARE BY MANUFACTURER, 2008 (%) 136
- TABLE 39 GLOBAL SPINAL CORD STIMULATOR MANUFACTURER MARKET SHARE BY
MANUFACTURER, 2008 137
- FIGURE 26 GLOBAL SPINAL CORD STIMULATOR MANUFACTURER MARKET SHARE, 2008
(%) 137
- FUTURE MARKET ANALYSIS 137
Chapter-8: TOTAL MARKET SUMMARY 3
- TOTAL PAIN MANAGEMENT MARKET 138
- TABLE 40 GLOBAL PAIN MANAGEMENT PHARMACEUTICALS AND DEVICES MARKET BY
CATEGORY, THROUGH 2013 ($ MILLIONS) 138
- FIGURE 27 GLOBAL PAIN MANAGEMENT PHARMACEUTICALS AND DEVICES MARKET BY
CATEGORY, 2006 - 2013 ($ MILLIONS) 139
- MARKET PERCENTAGE BY PRODUCT TYPE 139
- TABLE 41 PERCENT DISTRIBUTION OF THE WORLDWIDE PAIN MANAGEMENT MARKET BY
SEGMENT, 2008 (%, $ MILLIONS) 139
- FIGURE 28 PERCENT DISTRIBUTION OF THE WORLDWIDE PAIN MANAGEMENT MARKET BY
SEGMENT, 2008 (%) 140
Chapter-9: COMPANY PROFILES 10
- PHARMACEUTICAL PAIN MANAGEMENT MANUFACTURERS 141
- ABBOTT LABORATORIES 141
- ASTRAZENECA 141
- BARR LABORATORIES, INC. 142
- Barr Laboratories, Inc. (Continued) 143
- BAXTER INTERNATIONAL 144
- BRISTOL-MYERS SQUIBB CO. 144
- ELI LILLY & CO. 145
- GLAXOSMITHKLINE 145
- MEDTRONIC, INC. 146
- MERCK & CO., INC. 147
- ORTHO-MCNEIL PHARMACEUTICALS 148
- PFIZER 149
- WYETH 149
- Wyeth (Continued) 150
Chapter-10: APPENDIX I: SELECTED PAIN MANAGEMENT CLINICS BY STATE/ APPENDIX II: COMPANY NAMES AND ADDRESSES 45
APPENDIX I: SELECTED PAIN MANAGEMENT CLINICS BY STATE 151
- PAIN CLINICS 151
- TABLE 42 ALABAMA CLINICS 151
- TABLE 42 (CONTINUED) 152
- TABLE 43 CALIFORNIA PAIN CLINICS 152
- TABLE 43 (CONTINUED) 153
- TABLE 43 (CONTINUED) 154
- TABLE 43 (CONTINUED) 155
- TABLE 43 (CONTINUED) 156
- TABLE 43 (CONTINUED 157
- TABLE 43 (CONTINUED) 158
- TABLE 43 (CONTINUED) 159
- TABLE 43 (CONTINUED) 160
- TABLE 44 COLORADO PAIN CLINICS 160
- TABLE 44 (CONTINUED) 161
- TABLE 45 DELAWARE PAIN CLINICS 161
- TABLE 45 (CONTINUED) 162
- TABLE 46 FLORIDA PAIN CLINICS 162
- TABLE 46 (CONTINUED) 163
- TABLE 46 (CONTINUED) 164
- TABLE 46 (CONTINUED) 165
- TABLE 46 (CONTINUED) 166
- TABLE 46 (CONTINUED) 167
- TABLE 46 (CONTINUED) 168
- TABLE 47 HAWAII PAIN CLINICS 168
- TABLE 48 IOWA PAIN CLINICS 169
- TABLE 49 MAINE PAIN CLINICS 169
- TABLE 50 NEVADA PAIN CLINICS 170
- TABLE 51 OREGON PAIN CLINICS 170
- TABLE 51 (CONTINUED) 171
- TABLE 52 PENNSYLVANIA PAIN CLINICS 171
- TABLE 52 (CONTINUED) 172
- TABLE 52 (CONTINUED) 173
- TABLE 52 (CONTINUED) 174
- TABLE 53 RHODE ISLAND PAIN CLINICS 175
- TABLE 54 SOUTH DAKOTA PAIN CLINICS 175
- TABLE 55 TEXAS PAIN CLINICS 175
- TABLE 55 (CONTINUED) 176
- TABLE 55 (CONTINUED) 177
- TABLE 55 (CONTINUED) 178
- TABLE 56 WASHINGTON PAIN CLINICS 178
- TABLE 56 (CONTINUED) 179
- TABLE 56 (CONTINUED) 180
- PAIN SOCIETIES AND ASSOCIATIONS 180
- INTERNATIONAL ASSOCIATIONS AND ORGANIZATIONS 181
APPENDIX II: COMPANY NAMES AND ADDRESSES 182
- PAIN MANAGEMENT PHARMACEUTICAL MANUFACTURERS 182
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 183
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 184
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 185
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 186
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 188
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 189
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 190
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 191
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 193
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 194
- PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 195
|
